Updated ESMO prostate cancer guidelines released
medwireNews: ESMO has issued updated Clinical Practice Guidelines on prostate cancer covering all aspects of diagnosis, treatment, and follow-up.
The guidelines provide a comprehensive resource for clinicians and include recommendations on topics ranging from screening and diagnosis to the management of local or locoregional and metastatic disease.
The document also includes recommendations regarding precision medicine, including guidance on germline testing for cancer risk genes and treatment options for men harboring BRCA1/2 mutations, and palliative care.
As explained in the article published in the Annals of Oncology, the guidelines were developed by a multidisciplinary group of experts from across Europe, who followed ESMO’s standard operating procedure for Clinical Practice Guidelines.
medwireNews is an independent medical news service provided by Springer Healthcare. © 2020 Springer Healthcare part of the Springer Nature Group